Call for Abstract

12th International Conference onPharmacoepidemiology and Clinical Research , will be organized around the theme “Focused on all research activities for optimal use and safety of medication”

Pharmacoepidemiology Congress 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharmacoepidemiology Congress 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Pharmacoepidemiology is an extensive area of science which involves uses and effects of drugs in larger arena of population. Pharmacoepidemiology is a bridge of science which connects both pharmacology and epidemiology enhancing the informative study on topics apparently related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety, Pharmacovigilance, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions. This topic serves as a best way for Researchers to express their findings as research presentations on an array of Pharmacoepidemiology and Drug Safety. The main aim of Pharmacoepidemiology within the industry is to protect patients from unnecessary medication hazards by identifying the adverse effects, elucidating pre-disposing factors, refuting false safety signals and quantifying risk in relation to benefit. Clinical research  is the branch of science that involves the use of various medications, clinical therapeutics, medical and clinical devices, equipment and medical products for diagnosis and treatment of human disorders, diseases and patient safety.

  • Track 1-1 Prospective and Retrospective Cohort Studies
  • Track 1-2Molecular Pharmacoepidemiology
  • Track 1-3Psychotropics Pharmacoepidemiology
  • Track 1-4Clinical Research and Development
  • Track 1-5 Clinical Quality Assurance/Control
  • Track 1-6Clinical Compliance
  • Track 1-7Clinical and Therapeutic Drug Monitoring
  • Track 1-8Clinical Drug Reactions and Interventions
  • Track 1-9Pharmacogenetics and Biomarkers
  • Track 1-10Clinical Molecular Genetics
  • Track 1-11Paediatric Pharmacoepidemiology
  • Track 1-12Clinical Trials and Clinical Research Conducts
  • Track 1-13Pharmacoepidemiology And Pharmacoeconomics

Pharmacotherapy also known as drug therapy is the use of medical therapies (Surgical, Chemotherapy, Physical therapy, Radiation therapy) to treat disease. Drugs interact with receptors or enzymes present in cells, which promote healthy functioning and shave or cure illness. Drug Safety refers to the pharmacological science that ensures safety and is related to the collection, detection, assessment, monitoring, and prevention of adverse drug effects with pharmaceutical products. Safety monitoring in clinical trials involves the collection of adverse events, laboratory investigations including the planning, execution, data analysis and reporting of the safety information and details of the clinical examination of patients.

  • Track 2-1Drug Safety Regulations
  • Track 2-2Drug Safety Databases
  • Track 2-3Drug Safety Training
  • Track 2-4Drug Safety Surveillance
  • Track 2-5Drug Safety Services & Softwares
  • Track 2-6Drug Safety Reporting & Monitoring
  • Track 2-7Modern Pharmacotherapy
  • Track 2-8Patient Care
  • Track 2-9Home Medicine Review
  • Track 2-10Patient counselling

Action of Drugs also known Pharmacodynamics. It refers to the study of Drugs, its biochemical, physiologic effects, the mechanisms and its action on the body or on microorganisms and other parasites within or on the body. It deals with drug action, which is the initial consequence of a drug-receptor interaction, and drug effect, which refers to the subsequent effects. The drug action of digoxin, for example: The inhibition of membrane Na+/K+-ATPase; the drug effect is augmentation of cardiac contractility. In this example, the clinical response may comprise of improved exercise tolerance.

  • Track 3-1Adverse Drug Reactions
  • Track 3-2Modes of Drug Actions
  • Track 3-3Drug-Drug interactions
  • Track 3-4Drug-Food interactios
  • Track 3-5Drug-Chemical interactions
  • Track 3-6Idiosyncratic Reactions
  • Track 3-7Expected and un-expected Drug Reactions and its Reporting
  • Track 3-8Drug Dose and Clinical Response
  • Track 3-9Signal Transduction and Drug Action

Clinical research  is the branch of science that involves the use of various medications, clinical therapeutics, medical and clinical devices, equipment and medical products for diagnosis and treatment of human disorders, diseases and patient safety.

  • Track 4-1Research and Trials on Human Cells
  • Track 4-2Research in Pathology
  • Track 4-3Research and Studies on wounds and injuries
  • Track 4-4Clinical trials on rare diseases
  • Track 4-5Oncology and Clinical Research
  • Track 4-6Innovations in Preclinical Research
  • Track 4-7Stem Cells and Genetic Clinical Research
  • Track 4-8Microbiology And Clinical Research

Clinical trials describe the distinct procedures followed in development of new drugs. These are the characteristic studies intended for the treatment of behavioural symptoms among the medical intervention and a health outcome. Clinical trials comprise patient data, disease mechanisms, therapeutic interventions, epidemiology, clinical medicine, preclinical and clinical pharmacology, immunology, toxicological studies. Clinical trials consist of experimental clinical trials scrutinizes the new treatment replacing the placebo or existing alternative treatments and  safety methodology using data from observation of patients treated in clinical. Clinical data is the key feature translating basic research into medical care. The perfect conclusion of clinical trials is minimize risks, extend benefits and optimal use of an intervention of therapeutic drugs

  • Track 5-1Designing of Trials: Pre-Clinical Studies and different phases of Clinical Trials
  • Track 5-2Bioassay and its Types
  • Track 5-3Data collection and Quality Control
  • Track 5-4Alternative Trials Design and Models
  • Track 5-5Clinical Trials in Developing Countries
  • Track 5-6Innovations in Clinical Trials
  • Track 5-7Design of Clinical Studies and Trials
  • Track 5-8Clinical Trials in Developing Countries
  • Track 5-9Clinical Trials in different Diseases
  • Track 5-10Case Reports in Clinical Trials
  • Track 5-11CRO( Contract Research Organisation Clinical Trials)
  • Track 5-12Patient centric Clinical Trials
  • Track 5-13Nano Technology in Clinical Trials
  • Track 5-14In Silico Clinical Trials
  • Track 5-15Ethics in Clinical Trials

Pharmacology  is the study of interaction between substances with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals that show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are defined as pharmaceuticals. The Pharmacology encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and anti pathogenic capabilities.

  • Track 6-1Biochemical Pharmacology
  • Track 6-2EthnoPharmacology
  • Track 6-3Ocular Pharmacology
  • Track 6-4Cardiovascular Pharmacology
  • Track 6-5Neuro Pharmacology
  • Track 6-6Psycho Pharmacology
  • Track 6-7Immuno Pharmacology
  • Track 6-8Nursing Pharmacology
  • Track 6-9Pharmacological Testing
  • Track 6-10Advances In Pharmacological Research
  • Track 6-11Clinical Pharmacology and Receptor Theory

Pharmacoepidemiology is an extensive area of science which involves uses and effects of drugs in larger arena of population. Pharmacoepidemiology is a bridge of science which connects both pharmacology and epidemiology enhancing the informative study on topics apparently related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety, Pharmacovigilance, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions. This topic serves as a best way for Researchers to express their findings as research presentations on an array of Pharmacoepidemiology and Drug Safety. Public health describes “the science and art of preventing disease, lengthening life and further human health through methodized efforts and informed choices of society, organizations, public and private, communities and individuals." It is concerned with threats to health based on population health analysis .The focus of public health intercession is to promote health and quality of life through obstruction and treatment of disease and other physical and mental health conditions. This is done through supervision of cases and health indicators, and through advancement of healthy behaviours.

  • Track 7-1 Pharmacoepidemiology and Community Health
  • Track 7-2 Pharmacoepidemiology and Health Prevention
  • Track 7-3Public Health administration
  • Track 7-4Pharmacoepidemiology and Risk factor
  • Track 7-5Pharmacoepidemiology and Mental Health

Genetic epidemiology refers to “the role of genetic factors and genetic variations for determining health, disease in families and in populations and the interplay of such genetic factors with environmental factors. Genetic epidemiology seeks to derive a statistical and quantitative analysis of how genetics work in huge groups.

  • Track 8-1Molecular Epidemiology
  • Track 8-2PharmacoGenetics and Biomarkers
  • Track 8-3Clinical molecular genetics
  • Track 8-4Clinical Forensic Medicine
  • Track 9-1Disease management
  • Track 9-2HTA
  • Track 9-3Drug Utilization Research
  • Track 9-4Patient Reported Outcomes
  • Track 9-5Cost of Illness
  • Track 9-6MCDA
  • Track 9-7Budget Impact Analysis
  • Track 9-8Modelling
  • Track 9-9Health Economic Evaluation
  • Track 10-1Case Control Studies and Case Reports
  • Track 10-2Cross sectional study
  • Track 10-3Case Cross over Study
  • Track 11-1Population based Drug related Studies
  • Track 11-2Patterns of use
  • Track 11-3Drug efficacy
  • Track 11-4Rare Drug Adverse Events

Pharma compounds which were developed in the olden days were discovered and developed either by identifying the active ingredient from traditional remedies or by serendipitous discovery. But the advancements in the science and technology has made the job easier by controlling them at molecular and physiological level. During the phase of drug discovery main reason for the disease is identified and the possible pharmacological molecules are discovered. Later effect of that molecule on animals, humans is tested and if further improvements to be made, are performed. This involves many steps like identifying the reason for disease, lead identification, lead development, lead optimization, testing, and marketing.

  • Track 12-1Drug Discovery and Drug Screening
  • Track 12-2Study conduct and Optimization
  • Track 12-3ICH Guidelines for Clinical Research and its Statistics
  • Track 12-4Paperless clinical trials
  • Track 12-5Data Mining concepts and Techniques
  • Track 12-6SAS Programing in Clinical Research and Pharmacutical Industry
  • Track 12-7Clinical Research and Statistics
  • Track 12-8Global Clinical Innovations
  • Track 12-9Drug development and study design
  • Track 12-10Testing Molecular Compounds
  • Track 12-11Insights Into a Disease Process
  • Track 12-12Drug interactions
  • Track 12-13Misconduct and fraud in clinical trials

Databases contain professional assessment of the potential of drugs and permit the risk- profit analysis of medicinal products taking under consideration new and emerging information, within the context of additive data. These databases offer programming of alerts for fast cases, follow-up cases and reports submission to fulfil regulative timeline compliance. Data sources of pharmacoepidemiological databases are CPRD (Clinical Practice Research Data link), IMS Health Disease Analyser databases, PHARMO, Vigibase and Eudravigilance. Pharmacoepidemiology research studies may involve either data collected prospectively for the purpose of the particular study i.e. primary data, or data that were already collected for another purpose – as part of administrative records or patient health care , which is called secondary data.

  • Track 13-1PE data Sources
  • Track 13-2 Spontaneous Adverse Effect reporting
  • Track 13-3Global Drug Surveillance
  • Track 13-4Case Control Surveillance
  • Track 13-5SAS programming in data analysis
  • Track 13-6 Automated databases
  • Track 13-7Prescription event Monitoring
  • Track 13-8Data integration and visualization
  • Track 13-9On-shore & off-shore clinical data management
  • Track 13-10Advanced products in data management
  • Track 13-11Case report form (CRF/ECRF) design and development
  • Track 13-12Clinical data management system validation

Clinical Pharmacy and Pharmacy Practice involves developing the professional roles of pharmacists and is the order of drug store which includes adding to the expert parts of drug specialists. It includes Disease-state management, Clinical drug interventions, Pharmacy professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, drug abuse prevention, prevention of drug interactions or minimisation of adverse events and drug incompatibility and community pharmacy.

  • Track 14-1Pharmacy Practice and Patient Compliance
  • Track 14-2 Good Clinical Practices and Guidelines
  • Track 14-3Disease State Management
  • Track 14-4Patient Safety and Quality of Patient Care
  • Track 14-5Drug Discovery and Evaluation
  • Track 14-6Medical Practice and its Challenges

Pharmacovigilance plays a key role in all phases of clinical trials, including the planning, execution, data analysis and reporting of safety information and also bears an important responsibility for the expedited reporting of individual cases and safety updates required for regulatory authorities. The concept of Pharmacovigilance and its Significance enhances the impact of healthcare management on patient welfare and public health. Pharmacovigilance legislation gives an outlook on the rules and regulations to follow in Pharmacovigilance practice. The Role of Pharma industries in the improvement of Pharmacovigilance system is very crucial to maintain the safety data, detection and evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Eco Pharmacovigilance (EPV), Pharmacoenvironmentology and Pharmacovigilance in herbal medicines. In addition, data from observational epidemiological studies are playing an increasingly important role.

  • Track 15-1Pharmacovigilance and Healthcare System
  • Track 15-2Pharmacovigilance Legislation
  • Track 15-3Role of Pharma Industries in the Improvement of Pharmacovigilance System
  • Track 15-4 Detection and Evaluation of Drug safety Signals through Manual and Medical Devices reporting
  • Track 15-5 Ecopharmacovigilance (EPV), Pharmacoenvironmentology and Pharmacovigilance in herbal medicines
  • Track 15-6Methods of pharmacovigilance
  • Track 15-7Pharmacogenetic tests as tools in pharmacovigilance
  • Track 15-8Challenges and opportunities in PV lifecycle management

Pharma Risk Management was designed as a set of Pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks of medicinal and therapeutic products including the assessment of the effectiveness of their clinical reactions, interventions and combination therapies. Drug industry need to promote companies in Pharmacovigilance practice to use information technology and provide efficient software to implement the risk minimisation plans in drug development and manufacture. Pharmaceutical risk management monitors unlicensed, off labels and orphan drugs ,risk management labelling, regulatory decisions, legal protection, intellectual property, enforcement, marketing, and company reputation.

  • Track 16-1 Information Technology in Pharmacoepidemiology and Clinical Trials
  • Track 16-2Therapeutic Drug Management
  • Track 16-3Implementation of Risk Minimization Plans
  • Track 16-4Monitoring Unlicensed, off labels and Orphan Drugs
  • Track 16-5Risk Communication: Interface between Pharmaepidemiology, Sales and Marketing
  • Track 16-6Review of Softwares used in Pharmacovigilance and Clinical Trials
  • Track 16-7Risk Evaluation and Mitigation Strategies

Regulatory affairs is developed to protect public health by controlling the safety and efficacy of medical devices and pharmaceutical drug products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. Regulatory affairs (RA), also called government affairs, are a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom etc.

  • Track 17-1Pharmaceutical Research & Marketing
  • Track 17-2Regulations in Pharmacovigilance
  • Track 17-3Regulatory Authorities and Ethics Committee
  • Track 17-4Post Marketing Safety Surveillance
  • Track 17-5Drug Application systems (INDA, NDA, SNDA, ANDA)
  • Track 17-6Regulatory Authorities’ Guidelines Harmonization
  • Track 17-7USFDA, EU & MHRA